IHC staining was performed using the NSCLC cohort samples to assess p-ERK expression levels, the results of which showed a positive correlation between HBXIP expression and p-ERK activation (Figure 3A). The gene discussed is LAMTOR5; the disease is non-small cell lung carcinoma.